Indlela Lupus Ethinta Ngayo Isikhumba

Lokho ukukhwabanisa isikhumba kungakutshela uma une-lupus

I-Lupus iyisifo esizimele esingasithinta izingxenye eziningi zomzimba, kufaka phakathi amalunga , izinso , inhliziyo , namaphaphu. Ezinye izimpawu ezibonakalayo zesifo, noma kunjalo, zibandakanya isikhumba.

Ngokusho kweLupus Foundation of America, cishe izingxenye ezimbili kwezintathu zabantu abaphila ne-lupus bazobona uhlobo oluthile lwe-autoimmune-ezihlobene nezifo zesikhumba.

Ngaphezu kwalokho, noma yikuphi okuvela ngamaphesenti angama-40 ukuya kuma-70% kuzobona isimo sesikhumba esibucayi lapho sibhekwa emisebeni ye-ultraviolet (UV), kungaba ilanga noma imithombo yokufakelwa.

Kunezinhlobo ezintathu eziyinhloko zenkinga yesikhumba ebonwe kubantu abane-lupus:

I-Lupus Yomuntu Ongajwayelekile (i-Discoid Lupus)

I-lupus i-lupus (CCL) engapheli ichazwa ngokuphikelela kwesimo sesikhumba. Ifomu ejwayelekile kunazo zonke i-discoid lupus, ekhonjiswe ngama-scaly patches of skin abonakala kaningi emathuneni, emakhaleni nasezindlebeni. Bangakwazi futhi ukukhula ngemuva kwentamo, phezulu nangemuva kwezandla.

Ukuqaphela izilonda kungenzeka kube nokubukeka kwe-hypertrophic (obukhulu ne-scaly) noma obuhle (ukufana ne-wart). Uma ukuqubuka kuhilela indawo yesikhumba noma isilevu, kungabangela ukulahlekelwa izinwele ezibalulekile ( alopecia ). Ngaphezu kwalokho, noma yikuphi okushiya ngemuva kungenza kube nzima ukuba izinwele zikhule.

Ngisho nangemva kokuba izilonda ze-CCL zixazulule, zingashiya ama-patches esikhumba esikhanyayo noma esikhanyayo kanye ne-atrophy ebonakalayo (isikhumba esincane).

I-CCL ingase ibe nomkhawulo kuphela esikhumbeni noma isicoco esimweni esikhulu, esihleliwe esihilela ezinye izinhlelo zesitho. Odokotela bakhuluma kulokhu njenge- systemic lupus erythematosus (SLE) .

Konke okushiwo, cishe amaphesenti angu-10 abantu abane-discoid lupus bazokwakha i-SLE.

Ukuqaphela izilonda zisebenza ngokukhanya, ngakho yonke imizamo kufanele yenziwe ukuze ugweme ukukhanya kwelanga futhi usebenzise i-sunscreen ephakeme kune-SPF engu-30. Lokhu kubaluleke ikakhulukazi kusukela izilonda ezindala zingase zibeke umuntu isikhumba somdlavuza.

I-CCL izilonda zingasetshenziswa ngokuphekwa ngama- corticosteroid creams, amafutha, ama-gel, amateyipu kanye nezixazululo.

I-Subacute i-Lupus ehlukanisiwe

I-Subacute i-lupus i-lupus (SCL) yinkinga ehlukile emitholampilo yesifo sesikhumba esichazwe izinhlobo ezimbili ezahlukene zesilonda:

Izilonda ze-SCL zivame ukuvela ezingxenyeni ezikhanyisiwe zelanga zomzimba ezifana nezingalo, amahlombe, intamo, isiqu, futhi ngezinye izikhathi ubuso. Izilonda ngokwazo azigcini futhi azifani neze ezihlobene ne-SLE.

Njenge-lupus i-disco, abantu abane-SCL kufanele bagweme ukukhanya kwelanga kanye nemibhede yokuqothula njengoba lokhu kuzosondeza isimo. I-cortisone yocwaningo iyindlela ejwayelekile kakhulu yokwelapha.

I-Lupus ehlukanisiwe elula

I-lupus (i-ACL) enomtholampilo ebonakalayo ibonakala ngezindawo eziqhekekile zesikhumba esibomvu ezibonakala ebusweni ephathekayo, iphethini elinjenge-butterfly (eyaziwa nangokuthi i-rash rash).

Izilonda ezithinta izithombe zingase zihlakulele nasezingalweni, emilenzeni nasesitini.

Ngenkathi izilonda ze-ACL ngezinye izikhathi zingasulaza isikhumba, ngokuvamile azibazi. Ngakho-ke, noma yikuphi ukulahlekelwa izinwele okungase kwenzeke kungenzeka kube okwesikhashana.

Ukubukeka kwezilonda ze-ACL ngokuvamile kuvamise ukubonakala kwe-SLE futhi kungahle kuhambisane nezinye izinkinga zesikhumba ezinjengezinyosi, izilonda zomlomo, ne- vasculitis (imithwalo yegazi ewonakele ebonakala njengamahlumela abomvu noma ama-purplish, ngokuvamile emilenzeni engezansi).

Ngenxa yokuthi i-ACL ivame ukuyingxenye yomcimbi obanzi, isimiso se-system, i-steroids njenge- prednisone ingasetshenziswa ukuphatha ukuvuvukala futhi ihambisane nezidakamizwa zokuzivikela ekunciphiseni impendulo yokuzimela.

> Imithombo:

> Lupus Foundation of America. "Yeka ukuthi i-lupus ithinta kanjani isikhumba." Washington, DC; ishicilelwe ngoJulayi 12, 2013.

> Okon, L. kanye noWerth, V. "I-Lupus Erythematosus eyinqunyiwe: Ukuxilongwa nokuKwelashwa." I-Best Pract Res Clin Rheumatol. 2013; 27 (3): 391-404. I-DOI: 10.1016 / j.berh.2013.07.008.